BWL
ZOM

Bogart Wealth LLC’s Zomedica Corp. ZOM Stock Holding History

Bogart Wealth LLC’s Portfolio ZOM Stock Details ZOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$68 Hold
680
– – ﹤0.01% 1954
2026
Q1 		$81 Buy
680
+500
+278% +$60 ﹤0.01% 1748
2025
Q4 		$18 Hold
180
– – ﹤0.01% 1577
2025
Q3 		$14 Hold
180
– – ﹤0.01% 1525
2025
Q2 		$7 Hold
180
– – ﹤0.01% 1447
2025
Q1 		$10 Hold
180
– – ﹤0.01% 1400
2024
Q4 		$22 Hold
180
– – ﹤0.01% 1334
2024
Q3 		$25 Hold
180
– – ﹤0.01% 1121
2024
Q2 		$26 Hold
180
– – ﹤0.01% 1109
2024
Q1 		$26 Buy
+180
New +$25 ﹤0.01% 1066

Other funds holding ZOM

AA
Ancora Advisors Cleveland, Ohio $5.19B AUM 23.19% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return
GCP
Gill Capital Partners Denver, Colorado $378M AUM 18.32% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $7.43B AUM 24.49% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.72% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Bogart Wealth LLC's ZOM Position: Q2 2026 in Review

Bogart Wealth LLC held its Zomedica Corp. (ZOM) position steady in Q2 2026 at 680 shares worth $68. The position accounts for ﹤0.01% of the portfolio, ranked #1954.

Bogart Wealth LLC first reported a position in ZOM in Q1 2024 and has held it in 10 quarters since. The position peaked at $81 in Q1 2026. 7 funds tracked by Wall St. Rank hold ZOM as of Q2 2026.

  • Bogart Wealth LLC held 680 shares of Zomedica Corp. worth $68 as of Q2 2026.
  • Bogart Wealth LLC left its Zomedica Corp. share count unchanged in Q2 2026.
  • Zomedica Corp. made up ﹤0.01% of Bogart Wealth LLC's portfolio in Q2 2026, its #1954 holding.
  • Bogart Wealth LLC first reported a position in Zomedica Corp. in Q1 2024 and has held it in 10 quarters since.
  • Bogart Wealth LLC's Zomedica Corp. position peaked at $81 in Q1 2026.
  • 7 funds tracked by Wall St. Rank held Zomedica Corp. as of Q2 2026.

Based on Bogart Wealth LLC's 13F filing for Q2 2026, filed 24 Jul 2026.